Literature DB >> 11897088

Kappa opioid receptor is expressed by somatostatin- and neuropeptide Y-containing interneurons in the rat hippocampus.

Bence Rácz1, Katalin Halasy.   

Abstract

In our previous studies (J. Chem. Neuroanat. 2000;19:233-241), kappa opioid receptors were immunocytochemically identified in inhibitory interneurons of the dentate hilus and CA1 area of the rat hippocampus. From among the known interneuron subtypes, somatostatin- (SOM) and neuropeptide Y- (NPY) immunoreactive (IR) hippocampal interneurons show morphology and distribution similar to the kappa opioid receptor (KOR) immunopositive cells. In the present study, with the help of double immunocytochemical labelling, we provide direct evidence that the majority of the interneurons immunoreactive for SOM and/or NPY also express the kappa opioid receptor. The receptor was localized on the perikaryal and proximal dendritic region of the SOM- and NPY-immunopositive neurons in the dentate hilus and the CA1 region. From among the SOM-immunoreactive cells, 77% in the dentate hilus and 51% in the CA1 stratum oriens was double labelled. In the case of NPY-immunoreactive neurons this proportion was 56 and 65%, respectively. The co-expression of KOR and SOM/NPY suggests that hippocampal interneurons can selectively be activated by the different opioids under different physiological circumstances.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897088     DOI: 10.1016/s0006-8993(02)02259-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Structure/function correlates of neuronal and network activity--an overview.

Authors:  Fiona E N LeBeau; Miles A Whittington
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 3.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 4.  Sex differences in the rodent hippocampal opioid system following stress and oxycodone associated learning processes.

Authors:  Jasna Chalangal; Sanoara Mazid; Kyle Windisch; Teresa A Milner
Journal:  Pharmacol Biochem Behav       Date:  2021-11-06       Impact factor: 3.533

5.  Chronic stress differentially alters mRNA expression of opioid peptides and receptors in the dorsal hippocampus of female and male rats.

Authors:  Megan A Johnson; Natalina H Contoreggi; Joshua F Kogan; Matthew Bryson; Batsheva R Rubin; Jason D Gray; Mary Jeanne Kreek; Bruce S McEwen; Teresa A Milner
Journal:  J Comp Neurol       Date:  2021-02-08       Impact factor: 3.028

6.  An extrahippocampal projection from the dentate gyrus to the olfactory tubercle.

Authors:  Heinz Künzle
Journal:  BMC Neurosci       Date:  2005-05-31       Impact factor: 3.288

7.  The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion.

Authors:  Luca Zangrandi; Johannes Burtscher; James P MacKay; William F Colmers; Christoph Schwarzer
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

8.  Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression.

Authors:  Shalini Dogra; Ajeet Kumar; Deepmala Umrao; Amogh A Sahasrabuddhe; Prem N Yadav
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 9.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

10.  κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway.

Authors:  Jianing Fan; Long Li; Pengxia Qu; Yugang Diao; Yingjie Sun
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.